302 related articles for article (PubMed ID: 35134045)
1. COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
Med Lett Drugs Ther; 2022 Jan; 64(1642):16. PubMed ID: 35134045
[No Abstract] [Full Text] [Related]
2. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for children 5-11 years old.
Med Lett Drugs Ther; 2021 Nov; 63(1638):185. PubMed ID: 35085214
[No Abstract] [Full Text] [Related]
3. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637
[TBL] [Abstract][Full Text] [Related]
4. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
Woodworth KR; Moulia D; Collins JP; Hadler SC; Jones JM; Reddy SC; Chamberland M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Mbaeyi S; Dooling K; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(45):1579-1583. PubMed ID: 34758012
[TBL] [Abstract][Full Text] [Related]
5. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
[No Abstract] [Full Text] [Related]
6. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007
[TBL] [Abstract][Full Text] [Related]
7. In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults.
Med Lett Drugs Ther; 2021 Dec; 63(1640):201-202. PubMed ID: 35100238
[No Abstract] [Full Text] [Related]
8. Booster dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty).
Med Lett Drugs Ther; 2021 Oct; 63(1635):161-162. PubMed ID: 35050241
[No Abstract] [Full Text] [Related]
9. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
[TBL] [Abstract][Full Text] [Related]
11. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
Wallace M; Woodworth KR; Gargano JW; Scobie HM; Blain AE; Moulia D; Chamberland M; Reisman N; Hadler SC; MacNeil JR; Campos-Outcalt D; Morgan RL; Daley MF; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):749-752. PubMed ID: 34014913
[TBL] [Abstract][Full Text] [Related]
12. Myocarditis Associated With COVID-19 Booster Vaccination.
Aviram G; Viskin D; Topilsky Y; Sadon S; Shalmon T; Taieb P; Ghantous E; Flint N; Banai S; Havakuk O
Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013771. PubMed ID: 35100809
[No Abstract] [Full Text] [Related]
13. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
[TBL] [Abstract][Full Text] [Related]
14. New-onset cutaneous lupus erythematosus after the COVID-19 vaccine.
Liu V; Messenger NB
Dermatol Online J; 2021 Nov; 27(11):. PubMed ID: 35130405
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 update: Pfizer bivalent vaccine booster dose for children 6 months to 4 years old.
Med Lett Drugs Ther; 2023 Apr; 65(1674):63-64. PubMed ID: 37039615
[No Abstract] [Full Text] [Related]
16. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Shaw RH; Stuart A; Greenland M; Liu X; Nguyen Van-Tam JS; Snape MD;
Lancet; 2021 May; 397(10289):2043-2046. PubMed ID: 33991480
[No Abstract] [Full Text] [Related]
17. In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines.
Med Lett Drugs Ther; 2021 Jul; 63(1629):e9. PubMed ID: 34544112
[No Abstract] [Full Text] [Related]
18. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
Lavery MJ; Nawimana S; Parslew R; Stewart L
Clin Exp Dermatol; 2021 Oct; 46(7):1325-1327. PubMed ID: 33914926
[No Abstract] [Full Text] [Related]
19. Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male.
Sutcu M; Gul D; Atik F; Kara M
Malawi Med J; 2022 Jun; 34(2):154-156. PubMed ID: 35991822
[TBL] [Abstract][Full Text] [Related]
20. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
